Marinus, With Ztalmy Approval, Takes First Step Into Seizure Disorder Market

 
• By Jessica Merrill

The company will launch Ztalmy for an ultra-rare pediatric seizure disorder but hopes to expand to larger indications in the future. CEO Scott Braunstein talks to Scrip about the launch.

start line
Marinus has reached its commercial start • Source: Alamy

More from Rare Diseases

More from Scrip